CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities:
Net income	$ 483,707	$ 198,869
Depreciation and amortization of real estate, in-place lease and other intangibles:
Continuing operations	270,028	233,948
Discontinued operations		1,442
Amortization of above and below market lease intangibles, net	(3,271)	(5,337)
Stock-based compensation	15,286	11,306
Amortization of debt premiums, discounts and issuance costs, net	22,118	7,238
Straight-line rents	(46,936)	(32,869)
Interest accretion	(65,973)	(46,997)
Deferred rental revenues	(1,284)	(2,245)
Equity income from unconsolidated joint ventures	(32,798)	(4,078)
Distributions of earnings from unconsolidated joint ventures	2,462	5,441
Gain on sales of real estate		(4,052)
Gain upon consolidation of joint venture	(7,769)
Marketable securities gains, net		(5,642)
Gain upon settlement of loans receivable	(22,812)
Derivative (gains) losses, net	(1,226)	470
Impairments, net of recoveries	15,400	59,793
Changes in:
Accounts receivable, net	3,206	1,987
Other assets	28,631	1,181
Accounts payable and accrued liabilities	(71,848)	10,273
Net cash provided by operating activities	586,921	430,728
Cash flows from investing activities:
Cash used in the HCR ManorCare Acquisition, net of cash acquired	(4,026,556)
Cash used in the HCP Ventures II purchase, net of cash acquired	(135,550)
Other acquisitions and development of real estate	(170,629)	(228,297)
Leasing costs and tenant and capital improvements	(31,772)	(65,183)
Proceeds from sales of real estate, net		1,963
Purchase of an interest in and contributions to unconsolidated joint ventures	(95,000)	(6,445)
Distributions in excess of earnings from unconsolidated joint ventures	1,936	2,469
Purchases of marketable equity securities	(22,449)
Proceeds from the sale of marketable securities		72,749
Principal repayments on loans receivable and direct financing leases	303,867	28,494
Investments in loans receivable	(363,337)	(131,492)
Increase in restricted cash	(11,532)	(1,223)
Net cash used in investing activities	(4,551,022)	(326,965)
Cash flows from financing activities:
Net borrowings under bank line of credit	375,000	318,000
Repayment of term loan		(200,000)
Repayments of mortgage debt	(152,517)	(162,623)
Issuance of senior unsecured notes	2,400,000
Debt discounts and issuance costs	(43,716)
Repayment of senior unsecured notes	(292,265)	(200,000)
Net proceeds from the issuance of common stock and exercise of options	1,302,883	518,844
Dividends paid on common and preferred stock	(586,048)	(434,378)
Sale of noncontrolling interests	14,028	8,395
Purchase of noncontrolling interests	(34,104)
Distributions to noncontrolling interests	(11,001)	(11,625)
Net cash provided by (used in) financing activities	2,972,260	(163,387)
Net decrease in cash and cash equivalents	(991,841)	(59,624)
Cash and cash equivalents, beginning of period	1,036,701	112,259
Cash and cash equivalents, end of period	$ 44,860	$ 52,635